Project Grant R01EB035144

Award Date 9/1/24
Completion Date 5/31/28
Dollars Obligated $1.5M
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports the development of novel radiofluorination methods for rapidly accessing positron emission tomography (PET) imaging agents. The $505,848.59 award, spanning from September 1, 2024 to August 31, 2027, will fund research by the University of Pennsylvania to...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a laparoscopic probe prototype designed for detecting 511 keV gamma rays from PET radiotracers. The $161,000 award to the University of California, Davis will support the creation of a novel probe prototype with small Compton-angle collimation to...
The University of Washington has been awarded a Cooperative Agreement by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286). The $2,758,909 award, effective August 1, 2024 through May 31, 2029, supports the development of an innovative dual-mode breast cancer scanner that combines Positron Emission Tomography (PET) and X-Ray Tomosynthesis (DBT)....
This $665,435.00 Project Grant award from the National Cancer Institute's Cancer Research Manpower (CFDA 93.398) Federal Grant Program aims to develop a system capable of simultaneous multi-tracer Positron Emission Tomography (PET) imaging. The project will focus on enabling simultaneous PET imaging of multiple molecular probes by using tracers that emit both positrons and higher energy gamma photons. This will provide a more comprehensive understanding of biological processes in diseases like...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the CFDA program "Discovery and Applied Research for Technological Innovations to Improve Human Health" (93.286), aims to develop an optimized and accessible immuno-PET (Positron Emission Tomography) imaging platform using lipid nanoparticle (LNP) technology. The $707,813 award, with a project period from July 2024 to April 2027, will assess the ability of LNP-mRNA to synthesize...
This federal Project Grant award of $1,149,264 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286) aims to develop a rapid, inexpensive microfluidics-based approach for dose-on-demand production of ready-to-inject radiopharmaceuticals. The project seeks to dramatically reduce the barriers associated with radiopharmaceutical production, making...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $502,841 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to The Regents of the University of California, operating as Lawrence Berkeley National Laboratory (LBNL). The funding will support research and development of a novel detector readout concept for monolithic scintillation detectors that enables direct digitization...
This $384,863 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program supports research to develop a novel radiotracer imaging agent for detecting Gram-positive bacterial infections associated with implanted medical devices. The key products and services to be delivered include: In vitro testing of a bivalent radiotracer agent...
The federal Project Grant award R56EB033347, in the amount of $499,291.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The award will support the development of breakthrough technology to enable future compact, mid-field (0.7 Tesla) magnetic resonance imaging (MRI) systems, with the goal of improving accessibility and...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), provides $249,000 to Case Western Reserve University to develop an ultrafast photoacoustic histology platform for real-time intraoperative diagnosis. The project aims to create a structured illumination ultraviolet photoacoustic microscopy system capable of...

This federal Project Grant award, totaling $1,541,316.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286). The goal of this 4-year project is to develop a novel molecular imaging technology that combines Positron Emission Tomography (PET) and Ultrasound (US) imaging to enable real-time, interactive PET/US scanning and visualization of molecular contrast within US images. This innovative hybrid imaging system aims to improve the accuracy of US-guided tissue biopsies by incorporating PET tracer localization, supporting personalized precision medicine applications. The award recipient, The Washington University in St. Louis, will leverage its expertise in biomedical engineering and advanced imaging to create a compact, cost-effective PET/US device that can be integrated with existing clinical US scanners. The anticipated outcome is a new class of molecular imaging technology that provides anatomical, physiological, and molecularly-targeted information to enhance point-of-care clinical interventions.

Generated 7/1/25, 2:41 AM